Patents Represented by Attorney Chuck E. Dadswell
  • Patent number: 5877219
    Abstract: Described herein are non-steroidal ligands for the estrogen receptor which possess tissue-dependent estrogenic and antiestrogenic activity as well as methods for making the same and their applications in treating a variety of disease states.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: March 2, 1999
    Assignee: Glaxo WellcomeInc.
    Inventor: Timothy Mark Willson